The global OTC derivatives markets are still in transition. Regulatory pressure to increase transparency and to reduce risk exposures are both an opportunity and a challenge. In the light of a substantial amount of regulation currently in preparation, it has never been more important to stay ahead of the curve. Please join our international derivatives team for a discussion on the current legal challenges in the OTC derivative markets as seen from a US, English and German law perspective. The seminar will be moderated by our partner Patrick Scholl.
Topics to be addressed include:
- Update on the Dodd Frank, EMIR and MiFID II implementation, the clearing mandate and extraterritorial recognition. Which regulations are still outstanding and what can already be done today?
- Collateral requirements for non-cleared OTC derivatives, legal challenges and aspects of implementation. What changes to the legal documentation can be expected?
— Curtis Doty (New York), Ed Parker (London) and Patrick Scholl (Frankfurt)
- The new landscape of netting opinions post regulation. Will more opinions be required?
— Andreas Lange (Frankfurt)
The banking resolution regimes and bail-in, impact on OTC derivatives, securities lending transactions and repos. Are changes to the legal documentation required?
— Curtis Doty (New York) and Patrick Scholl (Frankfurt)
Please note that the event will be held in English.
Participation is free of charge.
For further information and registration please contact Frauke Launhardt, T +49 69 7941 1173.
3:20 p.m. – 6:00 p.m.
Coffee break included Drinks & Fingerfood to follow
Mayer Brown LLP
60327 Frankfurt am Main